27 November 2024
As reported by the ITA previously, a sample collected from the athlete by the ITA at the Asian Games Hangzhou 2022 during an in-competition anti-doping control performed on 4 October 2023 returned an Adverse Analytical Finding¹ for metandienone metabolite, a non-specified Prohibited Substance, according to the Prohibited List of the World Anti-Doping Agency (WADA).
On 21 November 2024, and further to a fully fledged hearing process during which the ITA represented the International Boxing Association (IBA), CAS ADD found that the athlete had committed an ADRV for the presence of a prohibited substance in accordance with Article 2.1 of the IBA anti-doping rules.
CAS ADD sanctioned Chinzorig Baatarsukh with 4 years of ineligibility. All results obtained by the athlete from 4 October 2023 (date of the ADRV) until 2 November 2023 (date of the provisional suspension) are disqualified.
The athlete has a right of appeal before the appeal division of CAS.
The ITA will not comment further on this case.